Back to Search
Start Over
Importance of position 170 in the inhibition of GES-type β-lactamases by clavulanic acid.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2011 Apr; Vol. 55 (4), pp. 1556-62. Date of Electronic Publication: 2011 Jan 10. - Publication Year :
- 2011
-
Abstract
- Bacterial resistance to β-lactam antibiotics (penicillins, cephalosporins, carbapenems, etc.) is commonly the result of the production of β-lactamases. The emergence of β-lactamases capable of turning over carbapenem antibiotics is of great concern, since these are often considered the last resort antibiotics in the treatment of life-threatening infections. β-Lactamases of the GES family are extended-spectrum enzymes that include members that have acquired carbapenemase activity through a single amino acid substitution at position 170. We investigated inhibition of the GES-1, -2, and -5 β-lactamases by the clinically important β-lactamase inhibitor clavulanic acid. While GES-1 and -5 are susceptible to inhibition by clavulanic acid, GES-2 shows the greatest susceptibility. This is the only variant to possess the canonical asparagine at position 170. The enzyme with asparagine, as opposed to glycine (GES-1) or serine (GES-5), then leads to a higher affinity for clavulanic acid (K(i) = 5 μM), a higher rate constant for inhibition, and a lower partition ratio (r ≈ 20). Asparagine at position 170 also results in the formation of stable complexes, such as a cross-linked species and a hydrated aldehyde. In contrast, serine at position 170 leads to formation of a long-lived trans-enamine species. These studies provide new insight into the importance of the residue at position 170 in determining the susceptibility of GES enzymes to clavulanic acid.
- Subjects :
- Asparagine genetics
Chromatography, Liquid
Glycine genetics
Microbial Sensitivity Tests
Serine genetics
Spectrometry, Mass, Electrospray Ionization
Structure-Activity Relationship
beta-Lactamases genetics
Anti-Bacterial Agents pharmacology
Clavulanic Acid pharmacology
Enzyme Inhibitors pharmacology
beta-Lactamase Inhibitors
beta-Lactamases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1098-6596
- Volume :
- 55
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 21220532
- Full Text :
- https://doi.org/10.1128/AAC.01292-10